News Story: Full Text
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

 

MOVING THE FIELD TOWARD MORE PATIENT-FOCUSED DRUG DEVELOPMENT

Al's Comment:

  This is an effort to push for the use of patients quality of life endpoints in clinical trials.  Anyone designing a clinical trial now should read this. It is a team effort of the Jumpstarting Brain Tumor Drug Development Coalition ( Accelerate Brain Cancer Cure (ABC2), Musella Foundation for Brain Tumor Research and Information, National Brain Tumor Society and the Society for Neuro-Oncology), led by David Arons of the NBTS


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://blog.braintumor.org/moving-the-field-toward-more-patient-focused-drug-development/?src=readmore&id=2326


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740